Malignant melanoma.
Schwartsmann
G
G
South American New Drug Development Office, Porto Allegre, Brazil.
Parkinson
D R
DR
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D008545:Melanoma / Q000235:genetics / Q000276:immunology / Q000628:therapy*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D016898:Interferon-alpha; D007376:Interleukin-2